BamSEC and AlphaSense Join Forces
Learn More

Avenue Therapeutics Inc. – Articles of Incorporation

OTC: ATXI    
Share price (10/7/26): $0.45    
Market cap (10/7/26): $1.479 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Avenue Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Avenue Therapeutics, Inc
12/34/56
EX-3.1
from S-3 1 page Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Avenue Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 18 pages Second Amended and Restated Bylaws of Avenue Therapeutics, Inc. Adopted February 9, 2023 I. Corporate Offices
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Avenue Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation of Avenue Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 21 pages Amended and Restated Bylaws of Avenue Therapeutics, Inc. I. Corporate Offices
12/34/56
EX-3.1
from 10-Q 2 pages Certificate of Amendment of the Third Amended and Restated Certificate of Incorporation of Avenue Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 12 pages Third Amended and Restated Certificate of Incorporation of Avenue Therapeutics, Inc
12/34/56
EX-3.2
from 10-12G 27 pages Bylaws of Avenue Therapeutics, Inc. I. Corporate Offices
12/34/56
EX-3.1
from 10-12G 12 pages Second Amended and Restated Certificate of Incorporation of Avenue Therapeutics Inc
12/34/56
EX-3.3
from 10-12G 27 pages Bylaws of Avenue Therapeutics, Inc. I. Corporate Offices
12/34/56
EX-3.2
from 10-12G 2 pages Certificate of Amendment of Amended and Restated Certificate of Incorporation of Avenue Therapeutics, Inc
12/34/56
EX-3.1
from 10-12G 10 pages Amended and Restated Certificate of Incorporation of Avenue Therapeutics, Inc
12/34/56